Obesity altered T cell metabolism and the response to infection

Current Opinion in Immunology

Volumn 46, Issue , 2017, Pages 1-7

  Green, William D ^a   Beck, Melinda A ^a  

^a University of North Carolina   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROGRAMMED DEATH 1 RECEPTOR; ADIPOCYTOKINE; BIOLOGICAL MARKER;

ADAPTIVE IMMUNITY; ADIPOCYTE; APOPTOSIS; CD4+ T LYMPHOCYTE; CELL DAMAGE; CELL FUNCTION; CELL METABOLISM; CELL SENESCENCE; CELL SURVIVAL; DISEASE ASSOCIATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFECTION; INFLUENZA A (H1N1); METABOLIC DISORDER; METABOLOME; NONHUMAN; OBESITY; PLASTICITY; REVIEW; RISK FACTOR; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL AGING; COMPLICATION; DISEASE PREDISPOSITION; ENERGY METABOLISM; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPOKINES; ANIMALS; BIOMARKERS; CELL SURVIVAL; CELLULAR SENESCENCE; DISEASE SUSCEPTIBILITY; ENERGY METABOLISM; HOST-PATHOGEN INTERACTIONS; HUMANS; INFECTION; LYMPHOCYTE ACTIVATION; OBESITY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 85016163675     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2017.03.008     Document Type: Review

References (59)

1. 1 van Panhuys, N., Klauschen, F., Germain, R.N., T-cell-receptor-dependent signal intensity dominantly controls CD4(+) T cell polarization in vivo. Immunity 41 (2014), 63–74.
2. 2 Brownlie, R.J., Zamoyska, R., T cell receptor signalling networks: branched, diversified and bounded. Nat Rev Immunol 13 (2013), 257–269.
3. 3 Michalek, R.D., Gerriets, V.A., Jacobs, S.R., Macintyre, A.N., MacIver, N.J., Mason, E.F., Sullivan, S.A., Nichols, A.G., Rathmell, J.C., Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol 186 (2011), 3299–3303.
4. 4 MacIver, N.J., Michalek, R.D., Rathmell, J.C., Metabolic regulation of T lymphocytes. Annu Rev Immunol 31 (2013), 259–283.
5. 5• Buck, M.D., O'Sullivan, D., Pearce, E.L., T cell metabolism drives immunity. J Exp Med 212 (2015), 1345–1360 The authors provide a concise and expansive summary of current knowledge on T cell metabolism and its contribution to the adaptive immune response. Topics discussed include metabolic states of T cells by different activation states and subsets as well as substrate utilization and function.
6. 6 Pearce, E.L., Poffenberger, M.C., Chang, C.H., Jones, R.G., Fueling immunity: insights into metabolism and lymphocyte function. Science, 342, 2013, 1242454.
7. 7 MacIver, N.J., Jacobs, S.R., Wieman, H.L., Wofford, J.A., Coloff, J.L., Rathmell, J.C., Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukocyte Biol 84 (2008), 949–957.
8. 8 Jacobs, S.R., Herman, C.E., MacIver, N.J., Wofford, J.A., Wieman, H.L., Hammen, J.J., Rathmell, J.C., Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol 180 (2008), 4476–4486.
9. 9 Pearce, E.L., Pearce, E.J., Metabolic pathways in immune cell activation and quiescence. Immunity 38 (2013), 633–643.
10. 10 Lochner, M., Berod, L., Sparwasser, T., Fatty acid metabolism in the regulation of T cell function. Trends Immunol 36 (2015), 81–91.
11. 11 Macintyre, A.N., Gerriets, V.A., Nichols, A.G., Michalek, R.D., Rudolph, M.C., Deoliveira, D., Anderson, S.M., Abel, E.D., Chen, B.J., Hale, L.P., et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab 20 (2014), 61–72.
12. 12 Gregor, M.F., Hotamisligil, G.S., Inflammatory mechanisms in obesity. Annu Rev Immunol 29 (2011), 415–445.
13. 13 Huttunen, R., Syrjanen, J., Obesity and the risk and outcome of infection. Int J Obes (Lond) 37 (2013), 333–340.
14. 14 Milner, J.J., Beck, M.A., The impact of obesity on the immune response to infection. Proc Nutr Soc 71 (2012), 298–306.
15. 15 Park, B.V., Pan, F., Metabolic regulation of T cell differentiation and function. Mol Immunol 68 (2015), 497–506.
16. 16 Jacobs, S.R., Michalek, R.D., Rathmell, J.C., IL-7 is essential for homeostatic control of T cell metabolism in vivo. J Immunol 184 (2010), 3461–3469.
17. 17 Weinberg, S.E., Chandel, N.S., Futility sustains memory T cells. Immunity 41 (2014), 1–3.
18. 18 O'Sullivan, D., van der Windt, G.J., Huang, S.C., Curtis, J.D., Chang, C.H., Buck, M.D., Qiu, J., Smith, A.M., Lam, W.Y., DiPlato, L.M., et al. Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 41 (2014), 75–88.
19. 19 van der Windt, G.J., Everts, B., Chang, C.H., Curtis, J.D., Freitas, T.C., Amiel, E., Pearce, E.J., Pearce, E.L., Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36 (2012), 68–78.
20. 20 van der Windt, G.J., O'Sullivan, D., Everts, B., Ching-Cheng Huang, S., Buck, M.D., Curtis, J.D., Chang, C., Smith, A.M., Ai, T., Faubert, B., Jones, R.G., Pearce, E.J., Pearce, E.L., CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability. PNAS 110 (2013), 14336–14341.
21. 21 Cui, G., Staron, M.M., Gray, S.M., Ho, P.C., Amezquita, R.A., Wu, J., Kaech, S.M., IL-7-induced glycerol transport and TAG synthesis promotes memory CD8+ T cell longevity. Cell 161 (2015), 750–761.
22. 22 Dong, W., Ding, T., Wu, L., Ren, X., Epling-Burnette, P.K., Yang, L., Effect of IL-7 and IL-15 on T cell phenotype in myelodysplastic syndromes. Oncotarget 7 (2016), 27479–27488.
23. 23• Renner, K., Geiselhoringer, A.L., Fante, M., Bruss, C., Farber, S., Schonhammer, G., Peter, K., Singer, K., Andreesen, R., Hoffmann, P., et al. Metabolic plasticity of human T cells: preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2-deoxy-glucose affects effector functions. Eur J Immunol 45 (2015), 2504–2516 The authors demonstrate alterations in human CD4 and CD8 T cell proliferative and functional responses when challenged with glycolytic and respiratory restriction. This investigation provides evidence linking metabolic flexibility of human T cells to effector functions, like cytokine production, and highlights translational insights from murine models.
24. 24 Battaglia, A., Buzzonetti, A., Baranello, C., Fanelli, M., Fossati, M., Catzola, V., Scambia, G., Fattorossi, A., Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-beta-induced regulatory T-cell development. Immunology 139 (2013), 109–120.
25. 25 Sheng, J., Chen, W., Zhu, H.J., The immune suppressive function of transforming growth factor-beta (TGF-beta) in human diseases. Growth Factors 33 (2015), 92–101.
26. 26•• Saucillo, D.C., Gerriets, V.A., Sheng, J., Rathmell, J.C., Maciver, N.J., Leptin metabolically licenses T cells for activation to link nutrition and immunity. J Immunol 192 (2014), 136–144 Here, the authors provide a novel link between lymphocyte activation and nutrition by illucidating leptin's impact on effector T cell metabolism. This finding provides an essential role for leptin in T cell mediated immunity.
27. 27 Pollizzi, K.N., Powell, J.D., Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat Rev Immunol 14 (2014), 435–446.
28. 28 Blagih, J., Coulombe, F., Vincent, E.E., Dupuy, F., Galicia-Vazquez, G., Yurchenko, E., Raissi, T.C., van der Windt, G.J., Viollet, B., Pearce, E.L., et al. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity 42 (2015), 41–54.
29. 29 Collaboration NRF, Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387 (2016), 1377–1396.
30. 30 Ogden, C.L., Carroll, M.D., Fryar, C.D., Flegal, K.M., Prevalence of obesity among adults and youth—United States, 2011–2014. NCHS Data Brief 219 (2015), 1–8.
31. 31 Louie, J.K., Acosta, M., Samuel, M.C., Schechter, R., Vugia, D.J., Harriman, K., Matyas, B.T., California Pandemic Working, G., A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 52 (2011), 301–312.
32. 32 Park, H.L., Shim, S.H., Lee, E.Y., Cho, W., Park, S., Jeon, H.J., Ahn, S.Y., Kim, H., Nam, J.H., Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine. Hum Vaccin Immunother 10 (2014), 1181–1186.
33. 33 Sheridan, P.A., Paich, H.A., Handy, J., Karlsson, E.A., Hudgens, M.G., Sammon, A.B., Holland, L.A., Weir, S., Noah, T.L., Beck, M.A., Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) 36 (2012), 1072–1077.
34. 34 Carolan, E., Hogan, A.E., Corrigan, M., Gaotswe, G., O'Connell, J., Foley, N., O'Neill, L.A., Cody, D., O'Shea, D., The impact of childhood obesity on inflammation, innate immune cell frequency, and metabolic microRNA expression. J Clin Endocrinol Metab 99 (2014), E474–E478.
35. 35 Paich, H.A., Sheridan, P.A., Handy, J., Karlsson, E.A., Schultz-Cherry, S., Hudgens, M.G., Noah, T.L., Weir, S.S., Beck, M.A., Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring) 21 (2013), 2377–2386.
36. 36 Costanzo, A.E., Taylor, K.R., Dutt, S., Han, P.P., Fujioka, K., Jameson, J.M., Obesity impairs gammadelta T cell homeostasis and antiviral function in humans. PLoS One, 10, 2015, e0120918.
37. 37 Mascitelli, L., Pezzetta, F., Goldstein, M.R., Leptin and regulatory T cells in obese patients with asthma. Thorax, 63, 2008, 659.
38. 38 Tagliabue, C., Principi, N., Giavoli, C., Esposito, S., Obesity: impact of infections and response to vaccines. Eur J Clin Microbiol Infect Dis 35 (2016), 325–331.
39. 39 Roth, J., Sahota, N., Patel, P., Mehdi, S.F., Wiese, M.M., Mahboob, H.B., Bravo, M., Eden, D.J., Bashir, M.A., Kumar, A., et al. Obesity paradox, obesity orthodox, and the metabolic syndrome: an approach to unity. Mol Med, 22, 2016.
40. 40 Nilsson, C., Raun, K., Yan, F.F., Larsen, M.O., Tang-Christensen, M., Laboratory animals as surrogate models of human obesity. Acta Pharmacol Sin 33 (2012), 173–181.
41. 1H NMR-based profiling reveals differential immune-metabolic networks during influenza virus infection in obese mice. PLoS One, 9, 2014, e97238.
42. 42•• Milner, J.J., Rebeles, J., Dhungana, S., Stewart, D.A., Sumner, S.C., Meyers, M.H., Mancuso, P., Beck, M.A., Obesity increases mortality and modulates the lung metabolome during pandemic H1N1 influenza virus infection in mice. J Immunol 194 (2015), 4846–4859 The authors demonstrate that obesity increases mortaltiy and lung inflammation in obese mice during pandemic H1N1 influenza virus infection. Furthermore, they provide a link between alterated metabolic profiles in obese mice and impaired cellular immune response.
43. 43 Reis, B.S., Lee, K., Fanok, M.H., Mascaraque, C., Amoury, M., Cohn, L.B., Rogoz, A., Dallner, O.S., Moraes-Vieira, P.M., Domingos, A.I., et al. Leptin receptor signaling in T cells is required for Th17 differentiation. J Immunol 194 (2015), 5253–5260.
44. 44 Deng, T., Lyon, C.J., Minze, L.J., Lin, J., Zou, J., Liu, J.Z., Ren, Y., Yin, Z., Hamilton, D.J., Reardon, P.R., et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab 17 (2013), 411–422.
45. 45 Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15 (2009), 914–920.
46. 46 McLaughlin, T., Liu, L.F., Lamendola, C., Shen, L., Morton, J., Rivas, H., Winer, D., Tolentino, L., Choi, O., Zhang, H., et al. T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler Thromb Vasc Biol 34 (2014), 2637–2643.
47. 47 Morris, D.L., Cho, K.W., DelProposto, J.L., Oatmen, K.E., Geletka, L.M., Martinez-Santibanez, G., Singer, K., Lumeng, C.N., Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes 62 (2013), 2762–2772.
48. 48 Cho, K.W., Morris, D.L., DelProposto, J.L., Geletka, L., Zamarron, B., Martinez-Santibanez, G., Meyer, K.A., Singer, K., O'Rourke, R.W., Lumeng, C.N., An MHC II-dependent activation loop between adipose tissue macrophages and CD4+ T cells controls obesity-induced inflammation. Cell Rep 9 (2014), 605–617.
49. + T cells. This finding links obesity to adipose tissue inflammation and changes in T cell activation and populations.
50. 50 Wang, C.Y., Kim, H.H., Hiroi, Y., Sawada, N., Salomone, S., Benjamin, L.E., Moskowitz, M.A., Liao, J.K., Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR. Sci Signal 2 (2009), 1–11.
51. 51 Palmer, A.K., Tchkonia, T., LeBrasseur, N.K., Chini, E.N., Xu, M., Kirkland, J.L., Cellular senescence in type 2 diabetes: a therapeutic opportunity. Diabetes 64 (2015), 2289–2298.
52. 52• Shirakawa, K., Yan, X., Shinmura, K., Endo, J., Kataoka, M., Katsumata, Y., Yamamoto, T., Anzai, A., Isobe, S., Yoshida, N., et al. Obesity accelerates T cell senescence in murine visceral adipose tissue. J Clin Invest 126 (2016), 4626–4639 The authors describe a senescent T cell phenotype in murine visceral adipose tissue (VAT) found in obese mice but not lean controls. This novel population of cells was shown to drive VAT inflammation through osteopontin production, connecting adipose tissue with immune aging.
53. 53 Lund, S.A., Giachelli, C.M., Scatena, M., The role of osteopontin in inflammatory processes. J Cell Commun Signal 3 (2009), 311–322.
54. 54 Jin, H.T., Ahmed, R., Okazaki, T., Role of PD-1 in regulating T-cell immunity. Curr Top Microbiol Immunol 350 (2011), 17–37.
55. 55 Charlton, J.J., Chatzidakis, I., Tsoukatou, D., Boumpas, D.T., Garinis, G.A., Mamalaki, C., Programmed death-1 shapes memory phenotype CD8 T cell subsets in a cell-intrinsic manner. J Immunol 190 (2013), 6104–6114.
56. 56 Wei, F., Zhong, S., Ma, Z., Kong, H., Medvec, A., Ahmed, R., Freeman, G.J., Krogsgaard, M., Riley, J.L., Strength of PD-1 signaling differentially affects T-cell effector functions. PNAS, 2013, E2480–E2489.
57. 57 Chang, C.H., Curtis, J.D., Maggi, L.B. Jr., Faubert, B., Villarino, A.V., O'Sullivan, D., Huang, S.C., van der Windt, G.J., Blagih, J., Qiu, J., et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153 (2013), 1239–1251.
58. 58 Simar, D., Versteyhe, S., Donkin, I., Liu, J., Hesson, L., Nylander, V., Fossum, A., Barres, R., DNA methylation is altered in B and NK lymphocytes in obese and type 2 diabetic human. Metabolism 63 (2014), 1188–1197.
59. 59 Jacobsen, M.J., Mentzel, C.M., Olesen, A.S., Huby, T., Jorgensen, C.B., Barres, R., Fredholm, M., Simar, D., Altered methylation profile of lymphocytes is concordant with perturbation of lipids metabolism and inflammatory response in obesity. J Diabetes Res, 2016, 2016, 8539057.